Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.45 |
| ▸ | TP53 | P04637 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31338688 | 0.87 | APP (0.44) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL31338705 | 0.84 | MAPT (0.49) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL31338693 | 0.80 | LMNA (0.47) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL31338679 | 0.73 | LMNA (0.53) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL804976 | 0.72 | LMNA (0.48) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL31338712 | 0.71 | FLT3 (0.52) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL31338708 | 0.69 | MAPT (0.67) | MAPTTP53LMNATHRBALDH1A1 | |
| SCHEMBL31338687 | 0.69 | MAPT (0.53) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL804949 | 0.69 | MAPT (0.44) | MAPTTP53LMNATHRBRXFP1 | |
| SCHEMBL13198307 | 0.68 | TP53 (0.66) | MAPTTP53LMNATHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741401-A1 | BENZOTHIAZOIMIDAZOLYL COMPOUND AND USE THEREOF | ER Stress Research Institute, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025009553-A1 | BENZOTHIAZOIMIDAZOLYL COMPOUND AND USE THEREOF | 小胞体ストレス研究所株式会社 | 2025-01-09 | — | — | WO | disclosed |